The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.

Bibliographic Details
Main Authors: D Black, I. R. Reid, J. A. Cauley, S Boonen, F Cosman, P C Leung, P Lakatos, Z Man, S. R. Cummings, T. F. Hue, M. E. Ruzycky, R Martinez, G Su, C Bucci-Rechtweg, R Eastell
Format: Article
Language:English
Published: Endocrinology Research Centre 2011-04-01
Series:Остеопороз и остеопатии
Online Access:https://endojournals.ru/index.php/osteo/article/view/4132

Similar Items